Literature DB >> 15048703

Frontline: Optimal T cell activation requires the engagement of CD6 and CD166.

Namir J Hassan1, A Neil Barclay, Marion H Brown.   

Abstract

The T cell surface glycoprotein, CD6 binds CD166 in the first example of an interaction between a scavenger receptor cysteine-rich domain and an immunoglobulin-like domain. We report that in human these proteins interact with a K(D) =0.4-1.0 microM and K(off) > or =0.4-0.63 s(-1), typical of many leukocyte membrane protein interactions. CD166 also interacts in a homophilic manner but with around 100-fold lower affinity (K(D) =29-48 microM and K(off) > or = 5.3 s(-1)). At concentrations, that will block the CD6/CD166 interaction, soluble monomeric CD6 and CD166 inhibit antigen-specific human T cell responses. This is consistent with extracellular engagement between CD6 and CD166 being required for an optimal immune response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15048703     DOI: 10.1002/eji.200424856

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  50 in total

1.  CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction.

Authors:  P Nair; R Melarkode; D Rajkumar; E Montero
Journal:  Clin Exp Immunol       Date:  2010-08-19       Impact factor: 4.330

2.  Platelets Play Differential Role During the Initiation and Progression of Autoimmune Neuroinflammation.

Authors:  Sarah C Starossom; Tatyana Veremeyko; Amanda W Y Yung; Marina Dukhinova; Cheryl Au; Alexander Y Lau; Howard L Weiner; Eugene D Ponomarev
Journal:  Circ Res       Date:  2015-08-20       Impact factor: 17.367

3.  Activated leucocyte cell adhesion molecule (ALCAM/CD166) regulates T cell responses in a murine model of food allergy.

Authors:  Y S Kim; M N Kim; K E Lee; J Y Hong; M S Oh; S Y Kim; K W Kim; M H Sohn
Journal:  Clin Exp Immunol       Date:  2018-02-20       Impact factor: 4.330

4.  ALCAM (CD166) is involved in extravasation of monocytes rather than T cells across the blood-brain barrier.

Authors:  Ruth Lyck; Marc-André Lécuyer; Michael Abadier; Christof B Wyss; Christoph Matti; Maria Rosito; Gaby Enzmann; Thomas Zeis; Laure Michel; Ana B García Martín; Federica Sallusto; Fabien Gosselet; Urban Deutsch; Joshua A Weiner; Nicole Schaeren-Wiemers; Alexandre Prat; Britta Engelhardt
Journal:  J Cereb Blood Flow Metab       Date:  2016-11-14       Impact factor: 6.200

5.  ALCAM/CD166 adhesive function is regulated by the tetraspanin CD9.

Authors:  Alvaro Gilsanz; Lorena Sánchez-Martín; María Dolores Gutiérrez-López; Susana Ovalle; Yesenia Machado-Pineda; Raquel Reyes; Guido W Swart; Carl G Figdor; Esther M Lafuente; Carlos Cabañas
Journal:  Cell Mol Life Sci       Date:  2012-09-30       Impact factor: 9.261

6.  Immunological evaluation of rheumatoid arthritis patients treated with itolizumab.

Authors:  Lazaro E Aira; Patricia Hernández; Dinorah Prada; Araceli Chico; Jorge A Gómez; Zuyén González; Karla Fuentes; Carmen Viada; Zaima Mazorra
Journal:  MAbs       Date:  2015-10-15       Impact factor: 5.857

Review 7.  Modulation of cell adhesion and migration through regulation of the immunoglobulin superfamily member ALCAM/CD166.

Authors:  Ariana von Lersner; Lenny Droesen; Andries Zijlstra
Journal:  Clin Exp Metastasis       Date:  2019-02-18       Impact factor: 5.150

8.  Gadd45a inhibits cell migration and invasion by altering the global RNA expression.

Authors:  Zhanhai Shan; Guiyuan Li; Qimin Zhan; Dan Li
Journal:  Cancer Biol Ther       Date:  2012-07-24       Impact factor: 4.742

9.  Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumab.

Authors:  Lazaro E Aira; Alejandro López-Requena; Dasha Fuentes; Liset Sánchez; Teresita Pérez; Aleida Urquiza; Heber Bautista; Leopoldina Falcón; Patricia Hernández; Zaima Mazorra
Journal:  MAbs       Date:  2014-03-04       Impact factor: 5.857

10.  A Proteomic Analysis of the Malignant Mesothelioma Secretome Using iTRAQ.

Authors:  Jenette Creaney; Ian M Dick; Justine S Leon; Bruce W S Robinson
Journal:  Cancer Genomics Proteomics       Date:  2017 Mar-Apr       Impact factor: 4.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.